Mondo Payments Supports the DOvEE Project.
The DOvEE Project’s mission is to help with the early detections and diagnosis of ovarian and endometrial cancers.
A brighter tomorrow for ovarian & endometrial cancer diagnosis.
The Silent Killer
Endometrial and ovarian cancers account for the top 4th cause of cancer deaths in women in Canada, cervical cancer is the 16th top killer.
8 women die from ovarian and endometrial cancers each day in Canada
Most ovarian and a subset of endometrial cancers (25%) are diagnosed in stage 3 and 4 when the cancer has spread due to vague/unspecific symptoms
The 5-year survival rate for ovarian and endometrial cancers diagnosed in stage 1 is close to 90% while those diagnosed in stage 4 drop to a 20% survival rate
About the DOvEE Project.
The DOvEE Project was first founded in 2008 by Dr. Lucy Gilbert, now Director of the Gynecology-Oncology Division at the Royal Victoria Hospital, Glen Site, in Montreal Quebec.
DOvEE is a research-based clinic that is affiliated with the McGill University Health Centre (MUHC), one of the top-tier research-based institutes in the world.
The fundamental goal of the DOvEE research clinic is to ensure that eligible women are offered easy, fast access to imperative, yet specialized, medical examinations, which will consequently allow for the early detection and diagnosis of ovarian and endometrial cancers.
Together, we can help make a difference.
The DOvEEgene test was developed by a team of dedicated Canadian doctors, professors and researchers to increase the proportion of women diagnosed in early stages of ovarian and endometrial Cancers; helping increase the chances of being cured..